EPZM
Income statement / Annual
Last year (2021), Epizyme, Inc.'s total revenue was $37.43 M,
an increase of 137.45% from the previous year.
In 2021, Epizyme, Inc.'s net income was -$251.12 M.
See Epizyme, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$37.43 M |
$15.76 M |
$23.80 M |
$21.70 M |
$10.00 M |
$8.01 M |
$2.56 M |
$41.41 M |
$68.48 M |
$45.22 M |
| Cost of Revenue |
$10.50 M
|
$5.07 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$26.93 M
|
$10.70 M
|
$23.80 M
|
$21.70 M
|
$10.00 M
|
$8.01 M
|
$2.56 M
|
$41.41 M
|
$68.48 M
|
$45.22 M
|
| Gross Profit Ratio |
0.72
|
0.68
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$130.97 M
|
$110.93 M
|
$132.64 M
|
$105.83 M
|
$109.66 M
|
$91.46 M
|
$111.21 M
|
$75.60 M
|
$57.57 M
|
$38.48 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$68.30 M
|
$43.97 M
|
$37.18 M
|
$28.37 M
|
$23.90 M
|
$20.87 M
|
$14.04 M
|
$7.51 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$133.96 M
|
$125.18 M
|
$68.30 M
|
$43.97 M
|
$37.18 M
|
$28.37 M
|
$23.90 M
|
$20.87 M
|
$14.04 M
|
$7.51 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$264.92 M
|
$236.11 M
|
$200.94 M
|
$149.81 M
|
$146.84 M
|
$119.83 M
|
$135.11 M
|
$96.46 M
|
$71.61 M
|
$45.99 M
|
| Cost And Expenses |
$275.42 M
|
$241.18 M
|
$200.94 M
|
$149.81 M
|
$146.84 M
|
$119.83 M
|
$135.11 M
|
$96.46 M
|
$71.61 M
|
$45.99 M
|
| Interest Income |
$0.00
|
$0.00
|
$7.11 M
|
$4.56 M
|
$2.17 M
|
$1.53 M
|
$94,000.00
|
$95,000.00
|
$74,000.00
|
$145,000.00
|
| Interest Expense |
$24.16 M
|
$6.07 M
|
$192,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$5.25 M
|
$3.98 M
|
$840,000.00
|
$1.05 M
|
$1.64 M
|
$1.59 M
|
$1.42 M
|
$742,000.00
|
$703,000.00
|
$847,000.00
|
| EBITDA |
-$221.69 M |
-$221.53 M |
-$169.21 M |
-$122.52 M |
-$133.01 M |
-$108.62 M |
-$130.96 M |
-$54.15 M |
-$2.43 M |
$146,000.00 |
| EBITDA Ratio |
-5.92
|
-14.05
|
-7.11
|
-5.65
|
-13.3
|
-13.57
|
-51.16
|
-1.31
|
-0.04
|
0
|
| Operating Income Ratio |
-6.06
|
-14.3
|
-7.44
|
-5.9
|
-13.68
|
-13.97
|
-51.78
|
-1.33
|
-0.05
|
-0.02
|
| Total Other Income/Expenses Net |
-$24.16 M
|
-$6.16 M
|
$6.91 M
|
$4.53 M
|
$2.20 M
|
$1.61 M
|
$173,000.00
|
$154,000.00
|
-$7,000.00
|
$67,000.00
|
| Income Before Tax |
-$251.10 M
|
-$231.58 M
|
-$170.24 M
|
-$123.57 M
|
-$134.65 M
|
-$110.21 M
|
-$132.38 M
|
-$54.90 M
|
-$3.13 M
|
-$701,000.00
|
| Income Before Tax Ratio |
-6.71
|
-14.69
|
-7.15
|
-5.69
|
-13.46
|
-13.76
|
-51.71
|
-1.33
|
-0.05
|
-0.02
|
| Income Tax Expense |
$22,000.00
|
$114,000.00
|
$58,000.00
|
$57,000.00
|
-$336,000.00
|
$1.61 M
|
$173,000.00
|
$109,000.00
|
$349,000.00
|
$1,000.00
|
| Net Income |
-$251.12 M
|
-$231.69 M
|
-$170.30 M
|
-$123.63 M
|
-$134.31 M
|
-$110.21 M
|
-$132.38 M
|
-$55.01 M
|
-$3.48 M
|
-$702,000.00
|
| Net Income Ratio |
-6.71
|
-14.7
|
-7.16
|
-5.7
|
-13.43
|
-13.76
|
-51.71
|
-1.33
|
-0.05
|
-0.02
|
| EPS |
-2.49 |
-2.29 |
-1.89 |
-1.72 |
-2.18 |
-1.93 |
-3.32 |
-1.67 |
-0.2 |
-0.0327 |
| EPS Diluted |
-2.49 |
-2.29 |
-1.89 |
-1.72 |
-2.18 |
-1.93 |
-3.32 |
-1.67 |
-0.2 |
-0.0327 |
| Weighted Average Shares Out |
$100.96 M
|
$100.96 M
|
$89.89 M
|
$71.86 M
|
$61.47 M
|
$57.13 M
|
$39.84 M
|
$33.03 M
|
$17.05 M
|
$21.45 M
|
| Weighted Average Shares Out Diluted |
$100.96 M
|
$100.96 M
|
$89.89 M
|
$71.86 M
|
$61.47 M
|
$57.13 M
|
$39.84 M
|
$33.03 M
|
$17.05 M
|
$21.45 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
